FDA approves Lupin's generic Topicort spray
The Food and Drug Administration has approved Lupin's generic Topicort (desoximetasone topical spray, 0.25%). The drug is a corticosteroid indicated to treat plaque psoriasis in patients ages 18 years and older.
Lupin's generic Topicort spray will be available in 30-, 50- and 100-ml. The product had U.S. sales of roughly $19.5 million for the 12 months ended January 2018, according to IQVIA data.
Lupin's generic Topicort spray will be available in 30-, 50- and 100-ml. The product had U.S. sales of roughly $19.5 million for the 12 months ended January 2018, according to IQVIA data.